| JHS Svendgaard Laboratories Ltd | Industry : (FMCG) | |
|---|---|---|
|
BSE Code : 532771 |
NSE Symbol : JHS |
P/E(TTM) : 0.00 |
|
ISIN Demat : INE544H01014 |
Div & Yield% : 0.00 |
EPS(TTM) : 0.00 |
|
Book Value(₹) : 20.03 |
Market Cap(₹Cr) : 70.80 |
Face Value(₹) : 10.00 |
| Particulars | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 32.70 | 23.27 | 22.28 | 23.45 | 25.17 | 22.66 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 32.70 | 23.27 | 22.28 | 23.45 | 25.17 | 22.66 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.73 | 0.59 | 1.14 | 1.00 | 1.42 | 0.27 |
| Total Income | 33.42 | 23.85 | 23.42 | 24.45 | 26.60 | 22.93 |
| Total Expenditure | 34.32 | 21.59 | 21.37 | 21.79 | 33.41 | 22.41 |
| PBIDT | -0.90 | 2.26 | 2.05 | 2.66 | -6.81 | 0.52 |
| Interest | 0.22 | 0.28 | 0.20 | 0.16 | 0.21 | 0.13 |
| PBDT | -1.12 | 1.98 | 1.85 | 2.50 | -7.03 | 0.39 |
| Depreciation | 1.86 | 1.90 | 1.86 | 1.88 | 2.02 | 1.97 |
| Tax | 0.41 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.18 | -0.71 | 0.18 | -0.43 | -2.09 | 0.25 |
| Reported Profit After Tax | -3.57 | 0.79 | -0.20 | 1.06 | -6.96 | -1.84 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | -2.86 | 0.00 |
| Adjusted Profit After Extra-ordinary item | -3.57 | 0.79 | -0.20 | 1.06 | -4.10 | -1.84 |
| EPS (Unit Curr.) | -0.42 | 0.09 | -0.02 | 0.12 | -0.84 | -0.21 |
| EPS (Adj) (Unit Curr.) | -0.42 | 0.09 | -0.02 | 0.12 | -0.84 | -0.21 |
| Calculated EPS (Unit Curr.) | -0.41 | 0.09 | -0.02 | 0.12 | -0.81 | -0.21 |
| Calculated EPS (Adj) (Unit Curr.) | -0.41 | 0.09 | -0.02 | 0.12 | -0.81 | -0.21 |
| Calculated EPS (Ann.) (Unit Curr.) | -1.63 | 0.37 | -0.09 | 0.49 | -3.25 | -0.86 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | -1.63 | 0.37 | -0.09 | 0.49 | -3.25 | -0.86 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 87.41 | 85.60 | 85.60 | 85.60 | 85.60 | 85.60 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | -2.75 | 9.71 | 9.20 | 11.34 | -27.06 | 2.29 |
| PBDTM(%) | -3.43 | 8.51 | 8.30 | 10.66 | -27.93 | 1.72 |
| PATM(%) | -10.92 | 3.39 | -0.90 | 4.52 | -27.65 | -8.12 |
